Loading...
Please wait, while we are loading the content...
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma.
| Content Provider | Europe PMC |
|---|---|
| Author | Richardson, Nicholas C. Kasamon, Yvette L. Chen, Haiyan de Claro, R. Angelo Ye, Jingjing Blumenthal, Gideon M. Farrell, Ann T. Pazdur, Richard |
| Page Count | 8 |
| ISSN | 10837159 |
| Journal | The Oncologist |
| Volume Number | 24 |
| PubMed Central reference number | PMC6516120 |
| Issue Number | 5 |
| PubMed reference number | 30914464 |
| e-ISSN | 1549490X |
| DOI | 10.1634/theoncologist.2019-0098 |
| Language | English |
| Publisher | John Wiley & Sons, Inc. |
| Publisher Date | 2019-03-26 |
| Publisher Place | Hoboken, USA |
| Access Restriction | Open |
| Rights License | Published 2019. This article is a U.S. Government work and is in the public domain in the USA |
| Subject Keyword | Adcetris Anaplastic large cell lymphoma Brentuximab vedotin CD30 antigen Peripheral T‐cell lymphoma |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cancer Research Oncology |